When traversing microvascular beds, such as in the lung, red blood cells (RBCs) are subjected to mechanical deformation. Our previous findings that RBCs are required for flow-induced nitric oxide (NO) synthesis in the lung and that mechanical deformation of RBCs results in the release of adenosine triphosphate (ATP), a stimulus for endothelial NO synthesis, suggested a novel mechanism for the control of vascular resistance in the pulmonary circulation. In this construct, as the RBC is increasingly deformed by increments in the velocity of blood flow through a vessel and/or by reductions in vascular caliber, it releases ATP which stimulates endothelial NO synthesis. The abluminal release of NO results in relaxation of vascular smooth muscle and, consequently, an increase in vascular caliber. This vasodilation results in a decrease in vascular resistance, and, thereby, a decrease in the stimulus for RBC deformation and ATP release. Thus, in response to RBC-derived ATP, abluminal release of NO would indirectly inhibit deformation-induced ATP release from RBCs via effects on vascular caliber. However, NO is also released into the vascular lumen by the endothelium in response to ATP. Therefore, in addition to effects on vascular caliber, it is possible that NO released into the vascular lumen could interact directly with circulating RBCs to modulate deformation-induced ATP release. Here, we address the hypothesis that: Deformation-induced ATP release from RBCs of rabbits and humans is regulated by nitric oxide via effects on the activity of a heterotrimeric G protein. In this proposal we intend to 1) establish that the effects of NO donors on deformation-induced ATP release from these RBCs are related to the release of NO, itself, 2) demonstrate that the ability of nitric oxide to inhibit ATP release from these RBCs is independent of an effect on RBC deformability per se, 3) demonstrate that nitric oxide inhibits deformation-induced ATP release from these RBCs as the result of inactivation of a heterotrimeric G protein of the Gi subclass and 4) demonstrate that the ability of nitric oxide to inhibit deformation-induced ATP release from RBCs of rabbits and humans is the result of the stimulation of mono-ADP-ribosylation (inactivation) of Gi and that this effect is reversible. The successful completion of the studies described in this proposal will define a new role for circulating RBCs as regulators of vascular resistance. This proposal is the logical extension of our previous work and is consistent with a major focus of our group, namely, characterization of those mechanisms responsible for the control of vascular resistance, and specifically, the role of RBC-derived ATP as a stimulus for endogenous NO synthesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL051298-05A1
Application #
6399104
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Garfinkel, Susan J
Project Start
1996-12-15
Project End
2005-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
5
Fiscal Year
2001
Total Cost
$218,973
Indirect Cost
Name
Saint Louis University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Ellsworth, M L; Ellis, C G; Sprague, R S (2016) Role of erythrocyte-released ATP in the regulation of microvascular oxygen supply in skeletal muscle. Acta Physiol (Oxf) 216:265-76
Sprague, Randy S; Ellsworth, Mary L (2012) Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication. Microcirculation 19:430-9
Ellsworth, Mary L; Ellis, Christopher G; Goldman, Daniel et al. (2009) Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 24:107-16
Sprague, Randy S; Stephenson, Alan H; Ellsworth, Mary L (2007) Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab 18:350-5
Moreland, K Trent; Procknow, Jesse D; Sprague, Randy S et al. (2007) Cyclooxygenase (COX)-1 and COX-2 participate in 5,6-epoxyeicosatrienoic acid-induced contraction of rabbit intralobar pulmonary arteries. J Pharmacol Exp Ther 321:446-54
Sprague, Randy; Stephenson, Alan; Bowles, Elizabeth et al. (2006) Expression of the heterotrimeric G protein Gi and ATP release are impaired in erythrocytes of humans with diabetes mellitus. Adv Exp Med Biol 588:207-16
Liang, Griffith; Stephenson, Alan H; Lonigro, Andrew J et al. (2005) Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs. Am J Physiol Heart Circ Physiol 288:H1580-5
Losapio, Jennifer L; Sprague, Randy S; Lonigro, Andrew J et al. (2005) 5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase. J Appl Physiol 99:1391-6
Olearczyk, Jeffrey J; Stephenson, Alan H; Lonigro, Andrew J et al. (2004) Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol Heart Circ Physiol 286:H940-5
Stephenson, Alan H; Sprague, Randy S; Losapio, Jennifer L et al. (2003) Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. Am J Physiol Heart Circ Physiol 284:H2153-61

Showing the most recent 10 out of 20 publications